Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2020-11-27
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$2.40+4,200207,400+2%+$10,068
2020-11-27
BCDABiocardia, Inc.Altman PeterPres, CEOS - Sale$2.31-3,200207,400-2%-$7,380
2020-11-30
BDTXBlack Diamond Therapeutics, Inc.Bolzon Bradley J PhdDir, 10%S - Sale$33.15-10,3931,680,323-1%-$344,513
2020-11-30
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10%S - Sale$33.15-10,3935,606,4240%-$344,513
D
2020-11-27
VIRVir Biotechnology, Inc.Virgin HerbertEVP, Research, CSOS - Sale+OE$30.00-2,93023,700-11%-$87,900
D
2020-11-30
MRNAModerna, Inc.Zaks Tal ZviChief Medical OfficerS - Sale+OE$147.76-20,0000-100%-$2,955,187
2020-11-30
BIIBBiogen Inc.Vounatsos MichelCEOP - Purchase$241.31+3,10034,810+10%+$748,047
2020-11-27
MRNAModerna, Inc.Bancel StephaneCEOS - Sale$119.22-21,04615,913,9420%-$2,509,220
2020-11-30
PSTIPluristem Therapeutics IncClover Wolf Capital - Limited Partnership10%P - Purchase$9.70+20,0004,077,5890%+$194,000
ADM
2019-01-02
DNLIDenali Therapeutics Inc.Ho CaroleChief Medical OfficerS - Sale+OE$19.44-17,500250,000-7%-$340,168
AD
2018-12-03
DNLIDenali Therapeutics Inc.Ho CaroleChief Medical OfficerS - Sale+OE$18.45-17,500250,000-7%-$322,834
AD
2018-11-15
DNLIDenali Therapeutics Inc.Ho CaroleChief Medical OfficerS - Sale+OE$18.07-17,500250,000-7%-$316,157
D
2020-11-27
STROSutro Biopharma, Inc.Hallam TrevorChief Scientific OfficerS - Sale+OE$17.01-2,39336,712-6%-$40,713
M
2020-11-25
HALOHalozyme Therapeutics, Inc.Kelley Kenneth JDirS - Sale$41.37-19,671266,711-7%-$813,850
2020-11-25
MRNAModerna, Inc.Bancel StephaneCEOS - Sale$99.20-9,00023,589,8680%-$892,800
D
2020-11-24
EXELExelixis, Inc.Marchesi Vincent TDirS - Sale+OE$18.50-40,00490,212-31%-$740,074
2020-11-25
HALOHalozyme Therapeutics, Inc.Henderson Jeffrey WilliamDirS - Sale$40.08-24,49847,609-34%-$981,757
2020-11-25
HALOHalozyme Therapeutics, Inc.Daly James MDirS - Sale$40.41-10,36321,002-33%-$418,800
D
2020-11-25
HALOHalozyme Therapeutics, Inc.Torley HelenPres, CEOS - Sale+OE$40.73-50,000480,522-9%-$2,036,568
D
2020-11-24
VIRVir Biotechnology, Inc.Virgin HerbertEVP, Research, CSOS - Sale+OE$27.29-2,34023,700-9%-$63,848
DM
2020-11-23
MRNAModerna, Inc.Hoge StephenPresS - Sale+OE$99.89-20,0001,890,646-1%-$1,997,711
D
2020-11-23
CRDFCardiff Oncology, Inc.Kelemen VickiEVP, COOS - Sale+OE$18.60-35,3215,054-87%-$657,020
D
2020-11-23
ADPTAdaptive Biotechnologies CorpTaylor Stacy LSVP, GCS - Sale+OE$46.30-2,8801,300-69%-$133,359
2020-11-23
PDLIPdl Biopharma, Inc.O'Farrell Elizabeth G.DirS - Sale$2.44-25,8260-100%-$63,015
2020-11-23
PDLIPdl Biopharma, Inc.Gryska David WDirS - Sale$2.43-50,000105,337-32%-$121,500
D
2020-11-20
KODKodiak Sciences Inc.Ehrlich JasonSee RemarksS - Sale+OE$138.79-6,95042,843-14%-$964,601
M
2020-11-20
CASICasi Pharmaceuticals, Inc.He Wei-WuCOB, CEOP - Purchase$2.15+227,47113,037,413+2%+$488,239
D
2020-11-23
MRNAModerna, Inc.Zaks Tal ZviChief Medical OfficerS - Sale+OE$100.53-15,0000-100%-$1,507,963
2020-11-20
MRNAModerna, Inc.Bancel StephaneCEOS - Sale$95.10-17,51414,537,0060%-$1,665,581
D
2020-11-23
VCELVericel CorpZerbe Robert L MdDirS - Sale+OE$23.55-17,50031,795-36%-$412,125
2020-11-23
MGTXMeiragtx Holdings PlcPerceptive Advisors LLCDir, 10%P - Purchase$12.85+500,0006,933,277+8%+$6,425,000
2020-11-23
VXRTVaxart, Inc.Latour WouterDirS - Sale$6.32-333,3340-100%-$2,108,138
D
2020-11-19
SGENSeagen Inc.Gryska David WDirS - Sale+OE$173.70-15,00044,848-25%-$2,605,523
D
2020-11-19
RGENRepligen CorpHunt AnthonyCEOS - Sale+OE$185.80-20,000233,327-8%-$3,716,051
2020-11-19
JNCEJounce Therapeutics, Inc.Third Rock Ventures Ii, L.P.10%S - Sale$7.00-15,0009,361,1370%-$105,075
2020-11-19
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10%S - Sale$33.01-130,0177,646,829-2%-$4,291,861
2020-11-19
JNCEJounce Therapeutics, Inc.Pfeffer CaryDirS - Sale$0.00-09,9170%-$0
2020-11-19
BDTXBlack Diamond Therapeutics, Inc.Bolzon Bradley J PhdDir, 10%S - Sale$33.01-130,0176,693,509-2%-$4,291,861
D
2020-11-19
ADPTAdaptive Biotechnologies CorpBenzeno SharonChief Business Development OffS - Sale+OE$48.86-4160-100%-$20,326
2020-11-18
PDLIPdl Biopharma, Inc.O'Farrell Elizabeth G.DirS - Sale$2.38-63,29125,826-71%-$150,696
D
2020-11-20
PDLIPdl Biopharma, Inc.Bazaar Alan LeeDirS - Sale+OE$2.42-33,43510,438-76%-$81,003
2020-11-20
HALOHalozyme Therapeutics, Inc.Labarre Michael J.SVP, Chief Technical OfficerS - Sale$38.76-12,000134,800-8%-$465,176
DM
2020-11-18
NSTGNanostring Technologies IncBailey K ThomasCFOS - Sale+OE$47.62-18,6460-100%-$887,926
D
2020-11-18
TECHBio-Techne CorpBaumgartner Robert VDirS - Sale+OE$303.33-5,0009,612-34%-$1,516,675
M
2020-11-18
MRNAModerna, Inc.Bancel StephaneCEOS - Sale$91.73-19,00023,617,3820%-$1,742,830
M
2020-11-17
BDTXBlack Diamond Therapeutics, Inc.Bolzon Bradley J PhdDir, 10%S - Sale$33.05-4,7306,808,3630%-$156,349
M
2020-11-17
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10%S - Sale$33.05-4,7307,776,8460%-$156,349
DM
2020-11-17
ADPTAdaptive Biotechnologies CorpRobins Chad MCEO, COBS - Sale+OE$46.99-50,0401,778,180-3%-$2,351,429
M
2020-11-17
MGTXMeiragtx Holdings PlcForbes AlexandriaPres, CEOS - Sale$15.16-16,6101,369,171-1%-$251,781
AM
2020-11-10
MGTXMeiragtx Holdings PlcForbes AlexandriaPres, CEOS - Sale$15.03-26,0191,385,781-2%-$391,149
2020-11-17
JNCEJounce Therapeutics, Inc.Pfeffer CaryDirS - Sale$0.00-09,9170%-$0
2020-11-17
JNCEJounce Therapeutics, Inc.Third Rock Ventures Ii, L.P.10%S - Sale$7.25-15,0009,376,1370%-$108,773
M
2020-11-17
PDLIPdl Biopharma, Inc.Gryska David WDirS - Sale$2.40-150,00095,337-61%-$359,500
D
2020-11-17
TCRRTcr2 Therapeutics Inc.Somaiya Mayur IanCFOS - Sale+OE$30.00-3,6661,473-71%-$109,980
2020-11-17
ORGOOrganogenesis Holdings Inc.Ades Alan A.Dir, 10%P - Purchase$3.25+833,153137,242,799+1%+$2,707,747
DM
2020-11-17
CHRSCoherus Biosciences, Inc.Anicetti Vincent RCOOS - Sale+OE$17.72-22,77032,569-41%-$403,510
D
2020-11-17
CHRSCoherus Biosciences, Inc.Viret Jean-FredericCFOS - Sale+OE$17.49-1,99540,269-5%-$34,896
D
2020-11-09
TECHBio-Techne CorpSeth AlpnaDirS - Sale+OE$306.62-5,0232,139-70%-$1,540,167
D
2020-11-16
ADPTAdaptive Biotechnologies CorpLo FrancisChief People OfficerS - Sale+OE$47.68-2,0002,500-44%-$95,351
D
2020-11-16
ADPTAdaptive Biotechnologies CorpGriffin Michelle ReneeDirS - Sale+OE$47.69-6,0000-100%-$286,135
D
2020-11-16
ADPTAdaptive Biotechnologies CorpHershberg RobertDirS - Sale+OE$47.69-2,0000-100%-$95,381
2020-11-16
REPLReplimune Group, Inc.Love ColinCOOS - Sale$44.91-15,0001,006,524-1%-$673,649
2020-11-16
RVMDRevolution Medicines, Inc.Column Group Iii, LP10%S - Sale$36.40-2,027,1565,950,228-25%-$73,788,478
2020-11-16
RVMDRevolution Medicines, Inc.Svennilson PeterDir, 10%S - Sale$36.40-2,027,1563,806,436-35%-$73,788,478
M
2020-11-16
ENZNEnzon Pharmaceuticals, Inc.Read Randolph CDirP - Purchase$0.15+100,450100,450New+$15,498
D
2020-11-16
NVAXNovavax IncErck Stanley CPres, CEOS - Sale+OE$90.65-52,31620,495-72%-$4,742,667
2020-11-16
ALLOAllogene Therapeutics, Inc.Schmidt Eric ThomasCFOS - Sale$32.88-15,0001,261,511-1%-$493,146
D
2020-11-16
NSTGNanostring Technologies IncBrown J. ChadSVP, Sales, MarketingS - Sale+OE$46.21-6,281440-93%-$290,245
D
2020-11-16
NSTGNanostring Technologies IncHershberg RobertDirS - Sale+OE$46.67-1,5001,890-44%-$70,002
2020-11-17
ATRAAtara Biotherapeutics, Inc.Koppikar UtpalCFOS - Sale$19.77-1,469132,061-1%-$29,048
2020-11-17
ATRAAtara Biotherapeutics, Inc.Newell JoeChief Operations OfficerS - Sale$19.77-1,648116,555-1%-$32,588
2020-11-17
ATRAAtara Biotherapeutics, Inc.Touchon PascalPres, CEOS - Sale$19.77-4,716255,321-2%-$93,254
2020-11-17
CVMCel Sci CorpYoung Peter RDirP - Purchase$11.68+80025,814+3%+$9,343
2020-11-18
CVMCel Sci CorpBaillavoine Bruno Jean-MarieDirP - Purchase$11.77+8004,723+20%+$9,416
2020-11-18
CVMCel Sci CorpWatson Robert EugeneDirP - Purchase$11.77+8003,181+34%+$9,416
M
2020-11-13
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10%S - Sale$33.74-4,7007,781,5760%-$158,587
M
2020-11-13
BDTXBlack Diamond Therapeutics, Inc.Bolzon Bradley J PhdDir, 10%S - Sale$33.74-4,7006,812,5410%-$158,587
2020-11-13
ENZNEnzon Pharmaceuticals, Inc.Bleznick JordanDirP - Purchase$0.15+100,000100,000New+$15,380
D
2020-11-16
MRNAModerna, Inc.Zaks Tal ZviChief Medical OfficerS - Sale+OE$96.99-15,0000-100%-$1,454,830
2020-11-12
NBIXNeurocrine Biosciences IncBenevich EricChief Commercial OfficerS - Sale$90.71-2,25717,405-11%-$204,723
2020-11-12
NBIXNeurocrine Biosciences IncRoberts EiryChief Medical OfficerS - Sale$90.74-2,25713,477-14%-$204,810
2020-11-12
NBIXNeurocrine Biosciences IncLloyd-Smith MalcolmChief Regulatory OfficerS - Sale$90.73-2,25729,002-7%-$204,776
2020-11-12
NBIXNeurocrine Biosciences IncLippoldt DarinGCS - Sale$90.72-2,25730,082-7%-$204,755
2020-11-12
NBIXNeurocrine Biosciences IncGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale$90.73-2,25781,624-3%-$204,784
2020-11-12
NBIXNeurocrine Biosciences IncGorman Kevin CharlesCEOS - Sale$90.78-3,390441,071-1%-$307,748
2020-11-12
NBIXNeurocrine Biosciences IncGano KyleChief Business Development OffS - Sale$90.73-2,25798,028-2%-$204,770
2020-11-12
NBIXNeurocrine Biosciences IncCooke JulieCHROS - Sale$90.73-2,25711,580-16%-$204,778
2020-11-12
NBIXNeurocrine Biosciences IncBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale$90.74-2,257152,694-1%-$204,806
2020-11-12
NBIXNeurocrine Biosciences IncAbernethy MattCFOS - Sale$90.74-2,25710,014-18%-$204,810
DM
2020-11-12
TWSTTwist Bioscience CorpWeiss PatrickCOOS - Sale+OE$105.05-7,10055,578-11%-$745,855
2020-11-16
FATEFate Therapeutics IncShoemaker Daniel DChief Scientific OfficerS - Sale$51.83-25,00093,091-21%-$1,295,746
2020-11-13
CVMCel Sci CorpCipriano JohnSVPS - Sale$12.73-10,00073,108-12%-$127,290
D
2020-11-13
ATRAAtara Biotherapeutics, Inc.Newell JoeChief Operations OfficerS - Sale+OE$18.49-7,500118,203-6%-$138,688
DM
2020-11-12
MRNAModerna, Inc.Hoge StephenPresS - Sale+OE$86.82-20,0001,900,646-1%-$1,736,475
M
2020-11-12
MRNAModerna, Inc.Bancel StephaneCEOS - Sale$86.05-21,04615,962,5020%-$1,810,902
DM
2020-11-12
FATEFate Therapeutics IncWolchko J ScottPres, CEOS - Sale+OE$51.87-60,000419,969-13%-$3,112,424
2020-11-11
ADPTAdaptive Biotechnologies CorpViking Global Investors LP10%S - Sale$49.52-2,500,00030,993,708-7%-$123,787,500
2020-11-11
ADPTAdaptive Biotechnologies CorpViking Global Performance LLC10%S - Sale$49.52-2,500,00030,993,708-7%-$123,787,500
2020-11-11
SURFSurface Oncology, Inc.Ross Robert W.Chief Medical OfficerS - Sale$10.05-595100,405-1%-$5,980
2020-11-12
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10%S - Sale$34.15-15,5985,927,0010%-$532,642
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top